Digital Health Stakeholder Directory

GE provides an eHealth Information Exchange technology platform that supports the secure exchange of patient data in virtually any scenario, between providers, across an integrated delivery network or accountable care organizations (ACO), among disparate vendors, or across geographies. The infrastructure is standards-based, scalable, and secure. The exchange is designed to integrate seamlessly with existing clinical workflows to take advantage of existing systems, accelerate provider adoption and enhance transparency.

Gecko Health Innovations develops a solution for medication adherence, with a focus on asthma. Via its sensor for inhalers and smartphone app patients can track asthma and COPD medications, symptoms, triggers, peak flow measurements, and flare-ups.

General Catalyst Partners is a venture capital firm that makes early-stage and growth equity investments. General Catalyst leverages its broad experience to help founders build market-leading businesses.

General Prognostics (GPx) is revolutionizing remote chronic disease management with the world's first bloodless blood tests. Headquartered in Boston, MA, GPx is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.

Genospace has built a comprehensive platform for genomic medicine. As the precision medicine platform of Sarah Cannon, they serve research, clinical development, pathology and clinical care teams who work with high-dimensional genomic and other biomedical data. Many of the most advanced precision medicine organizations are powered by Genospace.

GNS Healthcare is an AI-driven precision medicine company developing in silico patients from real world and clinical data to reveal the complex system of interactions underlying disease progression and drug response. In silico patients simulate drug response at the individual patient level to precisely match therapeutics to patients and rapidly discover key insights across drug discovery, clinical development, commercialization, and payor markets. GNS REFS causal AI technology integrates and transforms a wide-variety of patient data types into in silico patients across oncology, auto-immune diseases, neurology, and cardio-metabolic diseases. GNS partners with the world's leading biopharmaceutical companies and health plans and has validated its science and technology in over 50 peer-reviewed papers and abstracts.

Good Measures combine the expertise of a Registered Dietitian (RD) with the power of a state-of-the-art digital platform to help you make positive changes in your eating and exercise behavior. Based on inputs from you and your Registered Dietitian (RD), the Good Measures digital platform continuously generates highly customized meal and snack suggestions that address your near term nutritional needs, your food preferences, and your food restrictions.

Goodlux Medical offers SunSprite which helps patients self-manage depression by effectively using bright light therapy. The product consists of a wearable light tracker connected to a mobile app that provides real-time feedback to improve adherence and outcomes. Healthcare organizations benefit by managing depression on a population-health basis by engaging patients to self-manage their depression.